()
has been a registered insider since 2003.
As Chief Executive Officer at Apellis Pharmaceuticals, last made a transaction on 5/17/2023.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 8 |
50% |
17% |
4% |
139 |
1 Year |
8 |
0% |
-- |
-- |
-- |
| 8 |
63% |
21% |
10% |
194 |
9 Month |
8 |
0% |
-- |
-- |
-- |
| 8 |
63% |
10% |
20% |
100 |
6 Month |
8 |
0% |
-- |
-- |
-- |
| 9 |
44% |
2% |
-2% |
107 |
3 Month |
9 |
0% |
-- |
-- |
-- |
| 12 |
67% |
9% |
7% |
111 |
1 Month |
12 |
0% |
-- |
-- |
-- |
| 12 |
75% |
4% |
2% |
56 |
1 Week |
12 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 17 |
12% |
46% |
31% |
134 |
1 Year |
17 |
0% |
-- |
-- |
-- |
| 17 |
12% |
39% |
37% |
199 |
9 Month |
17 |
0% |
-- |
-- |
-- |
| 17 |
12% |
28% |
31% |
80 |
6 Month |
17 |
0% |
-- |
-- |
-- |
| 18 |
44% |
16% |
7% |
106 |
3 Month |
18 |
0% |
-- |
-- |
-- |
| 21 |
33% |
8% |
4% |
111 |
1 Month |
21 |
0% |
-- |
-- |
-- |
| 21 |
48% |
1% |
0% |
56 |
1 Week |
21 |
0% |
-- |
-- |
-- |
| Scorecards Updated 6/13/2023 07:11 PM EST |
Latest Transaction Date: |
5/17/2023 |
| Average days between Transaction and Entered Dates: |
2 |
